Insider Buying: Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) COO Buys 9,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) COO Jeff Shaner purchased 9,000 shares of the stock in a transaction dated Thursday, May 19th. The shares were acquired at an average cost of $2.90 per share, with a total value of $26,100.00. Following the acquisition, the chief operating officer now directly owns 1,221,952 shares in the company, valued at approximately $3,543,660.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

AVAH traded down $0.05 on Friday, reaching $2.88. The stock had a trading volume of 509,296 shares, compared to its average volume of 539,943. The firm has a 50-day moving average of $3.64 and a 200-day moving average of $5.41. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.09 and a fifty-two week high of $13.00. The company has a market capitalization of $532.03 million and a price-to-earnings ratio of -5.54. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 1.84.

Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last released its quarterly earnings results on Monday, March 28th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.01). Aveanna Healthcare had a negative net margin of 5.70% and a positive return on equity of 8.90%. The company had revenue of $414.07 million during the quarter, compared to the consensus estimate of $420.19 million. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.36 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Delphia USA Inc. bought a new stake in shares of Aveanna Healthcare in the 1st quarter valued at about $60,000. Goldman Sachs Group Inc. boosted its position in shares of Aveanna Healthcare by 1.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 384,154 shares of the company’s stock valued at $1,310,000 after purchasing an additional 4,286 shares in the last quarter. State Street Corp boosted its position in shares of Aveanna Healthcare by 0.9% during the 1st quarter. State Street Corp now owns 805,958 shares of the company’s stock valued at $2,748,000 after purchasing an additional 7,448 shares in the last quarter. Atria Wealth Solutions Inc. bought a new stake in shares of Aveanna Healthcare during the 1st quarter valued at about $91,000. Finally, Invesco Ltd. boosted its position in shares of Aveanna Healthcare by 63.1% during the 1st quarter. Invesco Ltd. now owns 201,243 shares of the company’s stock valued at $686,000 after purchasing an additional 77,869 shares in the last quarter. Hedge funds and other institutional investors own 95.00% of the company’s stock.

A number of equities analysts have recently commented on AVAH shares. Bank of America cut Aveanna Healthcare from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $10.00 to $5.50 in a report on Tuesday, March 29th. Deutsche Bank Aktiengesellschaft lowered their price target on Aveanna Healthcare from $12.50 to $6.00 and set a “buy” rating for the company in a report on Wednesday, March 30th. Raymond James lowered their price target on Aveanna Healthcare from $12.00 to $8.00 and set a “strong-buy” rating for the company in a report on Thursday, March 31st. Stephens lowered their price target on Aveanna Healthcare from $11.50 to $7.00 and set an “overweight” rating for the company in a report on Wednesday, March 30th. Finally, Credit Suisse Group lowered their price target on Aveanna Healthcare from $12.00 to $9.50 and set an “outperform” rating for the company in a report on Wednesday, March 30th. Three research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Aveanna Healthcare has an average rating of “Buy” and a consensus target price of $8.90.

About Aveanna Healthcare (Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

Recommended Stories